Molecular Diagnosis & Therapy

Adis, Springer Healthcare

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Molecular Diagnosis & Therapy is a journal published by Adis, Springer Healthcare in Switzerland. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Adis, Springer Healthcare
ISSN
1177-1062 · 1179-2000
Country
Switzerland
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2006-01-01
  • PUBMED · 2009-12-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
82 days received→accepted — computed from PubMed (n=73)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1151

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

72

i10-index

656

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
79%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Molecular diagnosis and therapy (OnlineMolecular diagnosis and therapy (PrintMolecular diagnosis & therapy (Print
Source type
journal
NLM unique ID (PubMed)
101264260
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Genomics and Rare Diseases
  • Pharmacogenetics and Drug Metabolism
  • Genetic Associations and Epidemiology
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
Show all subjects (75)
  • MicroRNA in disease regulation
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Metabolism and Genetic Disorders
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
  • BRCA gene mutations in cancer
  • Molecular Biology Techniques and Applications
  • Molecular Biology Techniques and Applications
  • Cancer-related molecular mechanisms research
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Breast Cancer Treatment Studies
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • Colorectal Cancer Treatments and Studies
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Virus-based gene therapy research
  • Cancer Immunotherapy and Biomarkers
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Prenatal Screening and Diagnostics
  • Cancer-related molecular mechanisms research
  • Bacterial Identification and Susceptibility Testing
  • Cancer-related molecular mechanisms research
  • Cancer Cells and Metastasis
  • Extracellular vesicles in disease
  • Cancer Cells and Metastasis
  • Genomic variations and chromosomal abnormalities
  • Genomic variations and chromosomal abnormalities
  • Biosensors and Analytical Detection
  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • HER2/EGFR in Cancer Research
  • Epigenetics and DNA Methylation
  • Molecular Biology Techniques and Applications
  • HER2/EGFR in Cancer Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • HER2/EGFR in Cancer Research
  • BRCA gene mutations in cancer
  • Lung Cancer Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Medical Imaging Techniques and Applications
  • Lysosomal Storage Disorders Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Genomic variations and chromosomal abnormalities
  • Prenatal Screening and Diagnostics
  • Prenatal Screening and Diagnostics
  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Asthma and respiratory diseases
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Prostate Cancer Treatment and Research
  • Asthma and respiratory diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: